Related Experiment Video
Updated: Jul 10, 2025

11:53
Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
27.4K
CRISPR/Cas12a Collateral Cleavage Activity for Sensitive 3'-5' Exonuclease Assay
Jae Hoon Jeung1,2, Hyogu Han1,3, Chang Yeol Lee4
1Material & Component Convergence R&D Department, Korea Institute of Industrial Technology (KITECH), Ansan 15588, Republic of Korea.
Biosensors
|November 24, 2023
Summary
This study introduces a CRISPR/Cas12a method for detecting 3'-5' exonuclease (Exo III) activity. The technique offers sensitive detection and can screen for Exo III inhibitors, aiding in disease research.
Area of Science:
- Molecular Biology
- Biochemistry
- Enzyme kinetics
Background:
- 3 -5 exonuclease (Exo III) enzymes are vital for cellular processes and linked to longevity.
- Dysregulation of Exo III is implicated in diseases like cancer, especially under stress.
Purpose of the Study:
- To develop a sensitive and specific method for detecting 3 -5 exonuclease (Exo III) activity.
- To utilize CRISPR/Cas12a technology for enzyme activity detection and inhibitor screening.
Main Methods:
- A CRISPR/Cas12a system was engineered with a hairpin probe (HP) containing an activator sequence.
- Exo III activity was detected by its hydrolysis of the HP's 3 -end, exposing the activator.
- Exposed activator triggered Cas12a collateral cleavage of a DNA signal probe, generating a fluorescent signal.
Main Results:
- The method achieved sensitive detection of Exo III activity down to 0.0073 U/mL.
- The technique demonstrated high specificity, leveraging Exo III's preference for dsDNA 3 -ends.
- The developed assay was successfully applied to screen for Exo III inhibitors.
Conclusions:
- The CRISPR/Cas12a-based approach provides a sensitive and specific platform for Exo III activity detection.
- This method is valuable for biochemical assays and screening potential therapeutic compounds targeting Exo III.
Related Concept Videos
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
CRISPR
51.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.8K

